Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion
| Journal | Volume 75 - 2012 |
| Issue | Fasc.3 - Letters |
| Author(s) | M. Sarikaya, E. Koçak, S. Köklü, A. Babali, B. çakal |
| Full article |
 VIEW FREE PDF |
| Department of Gastroenterology, Ankara Education and Research Hospital, Ankara, Turkey. |
|
The presence of hepatitis B e antigen (HBeAg) is often associated with ongoing liver disease, whereas HBeAg seroconversion often coincides with loss of serum hepatitis B virus (HBV) DNA, normalization of liver biochemical tests, clinical remission and sub sidence of hepatic inflammatory activity (1). Herein we desribe a patient with HBeAg reversion with acute liver failure after discontinuation of entecavir therapy. |
|
© Acta Gastro-Enterologica Belgica. PMID 23082714 |
